| # | Title | Journal | Year | Citations |
|---|
| 1 | Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis | Clinical Gastroenterology and Hepatology | 2012 | 1,624 |
| 2 | Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis | American Journal of Gastroenterology | 2014 | 595 |
| 3 | American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation | American Journal of Gastroenterology | 2014 | 503 |
| 4 | Prevalence of Symptoms Meeting Criteria for Irritable Bowel Syndrome in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis | American Journal of Gastroenterology | 2012 | 475 |
| 5 | Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis | American Journal of Gastroenterology | 2014 | 335 |
| 6 | Effect of Gender on Prevalence of Irritable Bowel Syndrome in the Community: Systematic Review and Meta-Analysis | American Journal of Gastroenterology | 2012 | 320 |
| 7 | Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis | The Lancet Gastroenterology and Hepatology | 2017 | 212 |
| 8 | British Society of Gastroenterology guidelines on the management of irritable bowel syndrome | Gut | 2021 | 212 |
| 9 | The influence of the brain–gut axis in inflammatory bowel disease and possible implications for treatment | The Lancet Gastroenterology and Hepatology | 2019 | 186 |
| 10 | Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis | Clinical Gastroenterology and Hepatology | 2013 | 141 |
| 11 | Ulcerative colitis | BMJ, The | 2013 | 122 |
| 12 | Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease | American Journal of Gastroenterology | 2016 | 117 |
| 13 | Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis | American Journal of Gastroenterology | 2017 | 117 |
| 14 | Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis | The Lancet Gastroenterology and Hepatology | 2020 | 109 |
| 15 | Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis | The Lancet Gastroenterology and Hepatology | 2020 | 108 |
| 16 | Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome–type Symptoms in Patients With Inflammatory Bowel Disease | Clinical Gastroenterology and Hepatology | 2017 | 87 |
| 17 | Nutritional management of Crohn’s disease | Therapeutic Advances in Gastroenterology | 2013 | 86 |
| 18 | Prevalence of Gastro-Esophageal Reflux-Type Symptoms in Individuals With Irritable Bowel Syndrome in the Community: A Meta-Analysis | American Journal of Gastroenterology | 2012 | 79 |
| 19 | Effect of Dyspepsia on Survival: A Longitudinal 10-Year Follow-Up Study | American Journal of Gastroenterology | 2012 | 74 |
| 20 | High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-Predominant Irritable Bowel Syndrome Based on Rome III Criteria | Clinical Gastroenterology and Hepatology | 2015 | 73 |
| 21 | Irritable bowel syndrome | BMJ, The | 2012 | 72 |
| 22 | Prevalence of functional gastrointestinal disorders among consecutive new patient referrals to a gastroenterology clinic | Frontline Gastroenterology | 2014 | 64 |
| 23 | Bidirectional brain–gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis | Gut | 2022 | 61 |
| 24 | The Effect of Dietary Intervention on Irritable Bowel Syndrome: A Systematic Review | Clinical and Translational Gastroenterology | 2015 | 48 |
| 25 | Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or 'psychomarkers'? | Nature Reviews Gastroenterology and Hepatology | 2014 | 47 |
| 26 | Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation | American Journal of Gastroenterology | 2016 | 41 |
| 27 | Efficacy of surgical or endoscopic treatment of idiopathic achalasia: a systematic review and network meta-analysis | The Lancet Gastroenterology and Hepatology | 2021 | 41 |
| 28 | Development and Validation of a Scoring System to Identify Patients With Microscopic Colitis | Clinical Gastroenterology and Hepatology | 2015 | 39 |
| 29 | Systematic Review and Network Meta-Analysis of Medical Therapies to Prevent Recurrence of Post-Operative Crohn’s Disease | Journal of Crohn's and Colitis | 2019 | 39 |
| 30 | Global prevalence of Barrett’s oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis | Gut | 2021 | 39 |
| 31 | Cyclic vomiting syndrome is a prevalent and under‐recognized condition in the gastroenterology outpatient clinic | Neurogastroenterology and Motility | 2018 | 37 |
| 32 | Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysis | BMJ, The | 2019 | 36 |
| 33 | IBS-like symptoms in patients with ulcerative colitis | Clinical and Experimental Gastroenterology | 2015 | 31 |
| 34 | Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome | Expert Review of Gastroenterology and Hepatology | 2016 | 26 |
| 35 | Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis | Journal of Crohn's and Colitis | 2021 | 26 |
| 36 | Best management of irritable bowel syndrome | Frontline Gastroenterology | 2021 | 25 |
| 37 | Placebo Response Rate in Clinical Trials of Fistulizing Crohn's Disease: Systematic Review and Meta-analysis | Clinical Gastroenterology and Hepatology | 2014 | 24 |
| 38 | Validation and modification of a diagnostic scoring system to predict microscopic colitis | Scandinavian Journal of Gastroenterology | 2016 | 16 |
| 39 | Laxatives for chronic constipation in adults | BMJ, The | 2012 | 15 |
| 40 | Dyspepsia | BMJ, The | 2013 | 12 |
| 41 | Effect of ACE inhibitors and angiotensin II receptor blockers on disease outcomes in inflammatory bowel disease | Gut | 2021 | 12 |
| 42 | Initial management of dyspepsia in primary care: an evidence-based approach | British Journal of General Practice | 2013 | 11 |
| 43 | The possible risks of proton pump inhibitors | Medical Journal of Australia | 2016 | 9 |
| 44 | The Importance of Smoking Cessation in Improving Disease Course in Crohn’s Disease | American Journal of Gastroenterology | 2016 | 8 |
| 45 | High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment | Therapeutic Advances in Gastroenterology | 2018 | 8 |
| 46 | Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome | Therapeutic Advances in Chronic Disease | 2013 | 7 |
| 47 | Stool as a treatment for IBS: more questions than answers? | The Lancet Gastroenterology and Hepatology | 2018 | 7 |
| 48 | Management of benign oesophageal strictures | Frontline Gastroenterology | 2019 | 7 |
| 49 | Irritable bowel syndrome | Clinical Evidence | 2012 | 7 |
| 50 | Use of Biomarkers in Irritable Bowel Syndrome: To Predict the Future, Look at the Past | Clinical and Translational Gastroenterology | 2015 | 6 |
